Developer docs
API playgroundTry for free, no card

Search company profiles

Odin Vision

Full company profile

uuid0006dz9

Namestring
Odin Vision
Legal namestring
Odin Medical Ltd.
Websiteurl
odin-vision.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Odin Vision is a London-based cloud-AI medical device company founded in 2019 as a University College London (UCL) spin-out. It develops computer-aided detection applications for endoscopic procedures, with two core products: CADDIE, a cloud-based AI system providing real-time polyp detection during colonoscopy, and CADU, an analogous AI solution for gastroscopy. Both products process live video feeds from endoscopy procedures using proprietary computer-vision algorithms; CADDIE is FDA-cleared and CE-marked under EU MDR and is described as the first AI-powered computer-aided detection application authorized in both the United States and Europe. Clinical evidence is anchored by the multicenter EAGLE Trial (841 patients, 22 endoscopists, 8 centers, 4 European countries) published in npj Digital Medicine, which demonstrated a 7.3% absolute increase in adenoma detection rate, 93% relative increase for large adenomas, and 230% relative increase in detection of sessile serrated lesions.

The company sells to acute-care hospitals, gastroenterology departments, and national cancer screening centers through an enterprise field-sales motion, with subscription-based licensing of its cloud-deployed software integrated into existing endoscopy workflows via a foot-pedal interface. In June 2023, Olympus Corporation acquired Odin Vision for $75.31 million, and the company now operates as a wholly-owned subsidiary within Olympus's OLYSENSE Intelligent Endoscopy Ecosystem, distributing globally through Olympus's medical-device sales infrastructure. Named deployments include Western General Hospital (UK), Princess Alexandra's Hospital Trust (UK), Sana Klinikum Berlin-Lichtenberg (Germany), and Military University Hospital Prague (Czech Republic). Revenue is not publicly disclosed; the company holds SOC 2 Type 1 and Type 2 certifications and operates with approximately 60 employees.

Short descriptiontext

Odin Vision is a London-based cloud-AI medical device company that develops FDA-cleared and CE-marked computer-aided detection software (CADDIE for colonoscopy, CADU for gastroscopy). Now an Olympus subsidiary, it serves hospitals and cancer screening centers via the OLYSENSE Intelligent Endoscopy Ecosystem.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI endoscopy software, polyp detection systems, computer-aided detection, cloud medical imaging, gastroenterology AI
Industry2 codes
1Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
CodeHLAHADABPrimaryYes
2End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
CodeHDAEANAAPrimaryNo
NAICS code2 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Computer Systems Design Services541512
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
AI Endoscopy Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1AI Medical Device Software
TypeSubscription Recurring
Description

CADDIE and CADU are AI-powered computer-aided detection software applications for endoscopy. Revenue is generated through licensing of the cloud-based AI system to hospitals and healthcare providers as part of the Olympus endoscopy ecosystem.

openpr.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Enterprise licensing for hospitals and healthcare systems
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed

en.acnnewswire.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1CADDIE
Description

Cloud-based AI for colonoscopy - real-time polyp detection during colonoscopy procedures

odin-vision.com
+1 more record
Core offering1 text field

Odin Vision develops cloud-based AI applications for endoscopic procedures, specifically CADDIE (real-time polyp detection during colonoscopy) and CADU (AI assistance for gastroscopy). Both products are FDA-cleared and CE-marked, deploy through the cloud to integrate with existing endoscopy workflows, and are now distributed as part of Olympus's OLYSENSE Intelligent Endoscopy Ecosystem following the June 2023 acquisition.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 7.3% absolute increase in adenoma detection rate
+3 more records
Product overview1 text field

Odin Vision is a cloud AI endoscopy company that provides two core products: CADDIE (cloud-based AI for colonoscopy) and CADU (cloud-based AI for gastroscopy). Both products are now integrated into Olympus's OLYSENSE Intelligent Endoscopy Ecosystem following the June 2023 acquisition. The products use computer vision AI to provide real-time polyp and lesion detection assistance during endoscopic procedures, helping clinicians improve adenoma detection rates and patient outcomes.

Product and service1 record
1CADDIE
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-06-01
Description

Olympus Corporation acquired Odin Vision for $75.31 million in June 2023 to integrate AI capabilities into its endoscopy product line. The acquisition enables Odin Vision's CADDIE and CADU AI solutions to be distributed globally through Olympus's OLYSENSE Intelligent Endoscopy Ecosystem.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Fujifilm is a major endoscopy equipment manufacturer with its own AI/advanced imaging initiatives, competing with Olympus's ecosystem (in which Odin Vision sits) for the same hospital gastroenterology buyers.

TypeEmerging player
Description

Virgo provides cloud-based AI for endoscopy video capture and analysis, overlapping with Odin Vision's cloud-AI architecture and hospital gastroenterology buyer, though its initial focus is on data capture and procedure recording rather than real-time polyp detection.

TypeDirect peer
Description

Iterative Health develops AI for gastroenterology including SKOUT, a polyp detection system for colonoscopy. It is a direct competitor to CADDIE in AI-CAD for GI endoscopy with overlapping hospital customers and a similar evidence-driven GTM motion.

TypeDirect peer
Description

Wision AI develops AI-assisted diagnostic software for colonoscopy, including polyp detection, making it a direct peer to Odin Vision in computer-aided detection for GI endoscopy.

TypeDirect peer
Description

Magentiq Eye is an AI colonoscopy company whose polyp detection software competes head-to-head with CADDIE in the same clinical use case, regulatory category, and hospital buyer segment.

TypeDirect peer
Description

Medtronic's GI Genius is the most prominent AI computer-aided detection system for colonoscopy, directly competing with Odin Vision's CADDIE in the same clinical workflow, customer base (hospital endoscopy departments), and regulatory category (FDA-cleared CAD).

TypeBroad incumbent
Description

Pentax Medical is a global endoscopy equipment manufacturer serving the same hospital GI departments as Odin Vision's customers, with overlapping procedural workflows and increasing AI-enabled imaging features.

TypeBroad incumbent
Description

Olympus is the parent of Odin Vision and the dominant endoscopy equipment manufacturer globally. Its OLYSENSE Intelligent Endoscopy Ecosystem now incorporates Odin Vision's AI, and Olympus offers broader endoscopy hardware, imaging, and service capabilities across the same customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Odin Vision

AI Endoscopy Softwareodin-vision.com

Odin Vision is a London-based cloud-AI medical device company that develops FDA-cleared and CE-marked computer-aided detection software (CADDIE for colonoscopy, CADU for gastroscopy). Now an Olympus subsidiary, it serves hospitals and cancer screening centers via the OLYSENSE Intelligent Endoscopy Ecosystem.

What Odin Vision does

Odin Vision is a London-based cloud-AI medical device company founded in 2019 as a University College London (UCL) spin-out. It develops computer-aided detection applications for endoscopic procedures, with two core products: CADDIE, a cloud-based AI system providing real-time polyp detection during colonoscopy, and CADU, an analogous AI solution for gastroscopy. Both products process live video feeds from endoscopy procedures using proprietary computer-vision algorithms; CADDIE is FDA-cleared and CE-marked under EU MDR and is described as the first AI-powered computer-aided detection application authorized in both the United States and Europe. Clinical evidence is anchored by the multicenter EAGLE Trial (841 patients, 22 endoscopists, 8 centers, 4 European countries) published in npj Digital Medicine, which demonstrated a 7.3% absolute increase in adenoma detection rate, 93% relative increase for large adenomas, and 230% relative increase in detection of sessile serrated lesions.

The company sells to acute-care hospitals, gastroenterology departments, and national cancer screening centers through an enterprise field-sales motion, with subscription-based licensing of its cloud-deployed software integrated into existing endoscopy workflows via a foot-pedal interface. In June 2023, Olympus Corporation acquired Odin Vision for $75.31 million, and the company now operates as a wholly-owned subsidiary within Olympus's OLYSENSE Intelligent Endoscopy Ecosystem, distributing globally through Olympus's medical-device sales infrastructure. Named deployments include Western General Hospital (UK), Princess Alexandra's Hospital Trust (UK), Sana Klinikum Berlin-Lichtenberg (Germany), and Military University Hospital Prague (Czech Republic). Revenue is not publicly disclosed; the company holds SOC 2 Type 1 and Type 2 certifications and operates with approximately 60 employees.

Odin Vision firmographics

Firmographics
Name
Odin Vision
Legal name
Odin Medical Ltd.
Website
https://odin-vision.com
Company type
Private
Founded year
2019
Operating status
Acquired
Headcount range
11–50 employees
Short description
Odin Vision is a London-based cloud-AI medical device company that develops FDA-cleared and CE-marked computer-aided detection software (CADDIE for colonoscopy, CADU for gastroscopy). Now an Olympus subsidiary, it serves hospitals and cancer screening centers via the OLYSENSE Intelligent Endoscopy Ecosystem.
Ownership category
akta.pro rank

Odin Vision industry classification

Industry
Product category
AI Endoscopy Software
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Computer Systems Design Services (541512)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)
akta.pro secondary industry
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)

Keywords

  • AI endoscopy software
  • Polyp detection systems
  • Computer-aided detection
  • Cloud medical imaging
  • Gastroenterology AI

Where Odin Vision is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Odin Vision business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. AI Medical Device Software: CADDIE and CADU are AI-powered computer-aided detection software applications for endoscopy. Revenue is generated through licensing of the cloud-based AI system to hospitals and healthcare providers as part of the Olympus endoscopy ecosystem.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise licensing for hospitals and healthcare systems

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Odin Vision product offering

Product offering

Core offering

Odin Vision develops cloud-based AI applications for endoscopic procedures, specifically CADDIE (real-time polyp detection during colonoscopy) and CADU (AI assistance for gastroscopy). Both products are FDA-cleared and CE-marked, deploy through the cloud to integrate with existing endoscopy workflows, and are now distributed as part of Olympus's OLYSENSE Intelligent Endoscopy Ecosystem following the June 2023 acquisition.

Product overview

Odin Vision is a cloud AI endoscopy company that provides two core products: CADDIE (cloud-based AI for colonoscopy) and CADU (cloud-based AI for gastroscopy). Both products are now integrated into Olympus's OLYSENSE Intelligent Endoscopy Ecosystem following the June 2023 acquisition. The products use computer vision AI to provide real-time polyp and lesion detection assistance during endoscopic procedures, helping clinicians improve adenoma detection rates and patient outcomes.

Differentiator

Problem solved

Functional benefit

Brands

  • CADDIE: Cloud-based AI for colonoscopy - real-time polyp detection during colonoscopy procedures
  • CADU

Products and services

  • CADDIE

Quantifiable outcome

  • 7.3% absolute increase in adenoma detection rate
  • +3 more outcomes

Companies that use Odin Vision

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Odin Vision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Odin Vision partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Olympus CorporationcoreOEM/ Whitelabel/ Licensing Partner · 1 June 2023Olympus Corporation acquired Odin Vision for $75.31 million in June 2023 to integrate AI capabilities into its endoscopy product line. The acquisition enables Odin Vision's CADDIE and CADU AI solutions to be distributed globally through Olympus's OLYSENSE Intelligent Endoscopy Ecosystem.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Odin Vision competitors and assessment

Company assessment

Broad incumbents

  • Fujifilm: Fujifilm is a major endoscopy equipment manufacturer with its own AI/advanced imaging initiatives, competing with Olympus's ecosystem (in which Odin Vision sits) for the same hospital gastroenterology buyers.
  • Pentax Medical (HOYA): Pentax Medical is a global endoscopy equipment manufacturer serving the same hospital GI departments as Odin Vision's customers, with overlapping procedural workflows and increasing AI-enabled imaging features.
  • Olympus Corporation: Olympus is the parent of Odin Vision and the dominant endoscopy equipment manufacturer globally. Its OLYSENSE Intelligent Endoscopy Ecosystem now incorporates Odin Vision's AI, and Olympus offers broader endoscopy hardware, imaging, and service capabilities across the same customer base.

Emerging players

  • Virgo Surgical Video Solutions: Virgo provides cloud-based AI for endoscopy video capture and analysis, overlapping with Odin Vision's cloud-AI architecture and hospital gastroenterology buyer, though its initial focus is on data capture and procedure recording rather than real-time polyp detection.

Direct peers

  • Iterative Health: Iterative Health develops AI for gastroenterology including SKOUT, a polyp detection system for colonoscopy. It is a direct competitor to CADDIE in AI-CAD for GI endoscopy with overlapping hospital customers and a similar evidence-driven GTM motion.
  • Wision AI: Wision AI develops AI-assisted diagnostic software for colonoscopy, including polyp detection, making it a direct peer to Odin Vision in computer-aided detection for GI endoscopy.
  • Magentiq Eye: Magentiq Eye is an AI colonoscopy company whose polyp detection software competes head-to-head with CADDIE in the same clinical use case, regulatory category, and hospital buyer segment.
  • Medtronic: Medtronic's GI Genius is the most prominent AI computer-aided detection system for colonoscopy, directly competing with Odin Vision's CADDIE in the same clinical workflow, customer base (hospital endoscopy departments), and regulatory category (FDA-cleared CAD).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Odin Vision social profiles

Digital presence

Odin Vision compliance and trust

Trust signal

Compliance4 records

Odin Vision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Odin Vision leadership team

Management profile

Number of profiles

Profiles9 records

Odin Vision funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Odin Vision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Odin Vision

What does Odin Vision do?

Odin Vision develops cloud-based AI applications for endoscopic procedures, specifically CADDIE (real-time polyp detection during colonoscopy) and CADU (AI assistance for gastroscopy). Both products are FDA-cleared and CE-marked, deploy through the cloud to integrate with existing endoscopy workflows, and are now distributed as part of Olympus's OLYSENSE Intelligent Endoscopy Ecosystem following the June 2023 acquisition.

Is Odin Vision a public or private company?

Odin Vision is a private company. It is classified as corporate owned and is currently acquired.

When was Odin Vision founded?

Odin Vision was founded in 2019. It employs 11 to 50 people.

Where is Odin Vision based?

Odin Vision is headquartered in London, United Kingdom, in the Europe region.

How does Odin Vision make money?

One revenue line is on record: AI Medical Device Software.

Who are Odin Vision's main competitors?

Broad incumbents on record are Fujifilm, Pentax Medical (HOYA) and Olympus Corporation. Virgo Surgical Video Solutions is listed as an emerging player. Direct peers are Iterative Health, Wision AI, Magentiq Eye and Medtronic.

Does Odin Vision have an API?

No public API is recorded for Odin Vision.

What industry is Odin Vision in?

Odin Vision's product category is AI Endoscopy Software. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation), with a secondary code of HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management). Its NAICS code is 3345 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireAI in Endoscopy Market Surges to $46.53 Billion by 2030 Driven by Technological AdvancementsThe AI in endoscopy market is projected to grow from $13.52 billion in 2025 to $46.53 billion by 2030, at a compound annual growth rate of 28%, driven by increasing gastrointestinal disease prevalence, technological advances in medical imaging algorithms, and rising demand for early cancer detection. Olympus Corporation acquired UK-based Odin Vision Ltd. in 2023 for $77.47 million to integrate cloud-based AI solutions into its endoscopy offerings, while Ainex Corporation launched its Endoscopy AI System in 2024. North America led the market in 2025, with Asia-Pacific expected to be the fastest-growing region through the forecast period.openPR.comKey Players and Competitive Overview in the Computer-Aided Detection MarketThe computer-aided detection market is projected to grow to $1.69 billion by 2030, driven by increasing demand for early disease diagnosis and AI-powered diagnostic systems. Olympus Corporation acquired UK-based Odin Vision for $75.31 million in June 2023 to integrate AI capabilities into its endoscopy product line, while Abbott Laboratories launched its Volt Pulsed Field Ablation System in January 2024 for atrial fibrillation treatment with initial trials in Australia.Precedence ResearchAI In Endoscopy Market Size to Hit USD 21.65 Billion by 2035The global AI in endoscopy market was valued at USD 2.14 billion in 2025 and is projected to reach USD 21.65 billion by 2035, growing at a CAGR of 26.04%, driven by increasing adoption of AI-assisted endoscopy systems that enhance diagnostic accuracy and workflow efficiency. North America led the market with a 45% share in 2025, while Asia-Pacific is expected to record the fastest growth through 2035. Key developments include Fujifilm India's establishment of local endoscopy manufacturing in Jodhpur, Olympus subsidiary Odin Vision's CE marking for cloud-AI devices, and Cosmo Pharmaceuticals' R&D agreement to expand AI-based CADe systems for Barrett's esophagus.OlympusamericaFirst Cloud-Based AI Endoscopy System for Colonoscopy Receives FDA ClearanceOdin Medical Ltd., a subsidiary of Olympus Corporation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the CADDIE™ computer-aided detection device, the first cloud-based AI technology for assisting in colonoscopy procedures. The device utilizes real-time video analysis to alert gastroenterologists to potential colorectal polyps, with clinical trials demonstrating improved adenoma detection rates without increasing procedural risks. This regulatory approval enables the remote updating of AI software to help hospitals maintain current diagnostic capabilities.